Discontinuing Disease Modifying Therapy in Progressive Multiple Sclerosis - Can We Stop What We Have Started?

被引:0
|
作者
Lonergan, Roisin
Kinsella, Katie
Duggan, Marguerite
Jordan, Sinead
Bradley, David
Hutchinson, Michael
Tubridy, Niall
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A547 / A547
页数:1
相关论文
共 50 条
  • [21] Oral Disease-Modifying Therapies for Multiple Sclerosis: Are We There Yet?
    Vijayshree Yadav
    Dennis Bourdette
    Current Neurology and Neuroscience Reports, 2010, 10 (5) : 333 - 335
  • [22] VCSELs in '98: What we have and what we can expect
    Coldren, LA
    Hegblom, ER
    Akulova, YA
    Ko, J
    Strzelecka, EM
    Hu, SY
    VERTICAL-CAVITY SURFACE-EMITTING LASERS II, 1998, 3286 : 2 - 16
  • [23] Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis
    Hartung, Hans-Peter
    Meuth, Sven G.
    Miller, Deborah M.
    Comi, Giancarlo
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (04) : 598 - 603
  • [24] Gray matter imaging in multiple sclerosis: what have we learned?
    Hanneke E Hulst
    Jeroen JG Geurts
    BMC Neurology, 11
  • [25] Gray matter imaging in multiple sclerosis: what have we learned?
    Hulst, Hanneke E.
    Geurts, Jeroen J. G.
    BMC NEUROLOGY, 2011, 11
  • [26] What Have We Learned from Perfusion MRI in Multiple Sclerosis?
    Lapointe, E.
    Li, D. K. B.
    Traboulsee, A. L.
    Rauscher, A.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2018, 39 (06) : 994 - 1000
  • [27] Fatigue in multiple sclerosis: can we measure it and can we treat it?
    Deluca, John
    JOURNAL OF NEUROLOGY, 2024, : 6388 - 6392
  • [28] Stop the dicing in hematopoiesis What have we learned?
    Alemdehy, Mir Farshid
    Erkeland, Stefan J.
    CELL CYCLE, 2012, 11 (15) : 2799 - 2807
  • [29] Can we predict multiple sclerosis?
    Ramagopalan, Sreeram V.
    Giovannoni, Gavin
    LANCET NEUROLOGY, 2009, 8 (12): : 1077 - 1079
  • [30] What have we learned and what can we do about NPS?
    D'Agnone, Oscar
    DRUGS AND ALCOHOL TODAY, 2015, 15 (01) : 28 - 37